These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 12919919

  • 1. [Early diagnosis of Kawasaki disease complicated by coronary artery lesions].
    Hu XH, Xu SX, Luan Z.
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Aug; 23(8):853-5. PubMed ID: 12919919
    [Abstract] [Full Text] [Related]

  • 2. Predictors of coronary artery lesions after intravenous gamma-globulin treatment in Kawasaki disease.
    Mori M, Imagawa T, Yasui K, Kanaya A, Yokota S.
    J Pediatr; 2000 Aug; 137(2):177-80. PubMed ID: 10931408
    [Abstract] [Full Text] [Related]

  • 3. Persistent monocytosis after intravenous immunoglobulin therapy correlated with the development of coronary artery lesions in patients with Kawasaki disease.
    Kuo HC, Wang CL, Liang CD, Yu HR, Chen HH, Wang L, Yang KD.
    J Microbiol Immunol Infect; 2007 Oct; 40(5):395-400. PubMed ID: 17932598
    [Abstract] [Full Text] [Related]

  • 4. Elevated levels of high-sensitivity C-reactive protein and serum amyloid-A late after Kawasaki disease: association between inflammation and late coronary sequelae in Kawasaki disease.
    Mitani Y, Sawada H, Hayakawa H, Aoki K, Ohashi H, Matsumura M, Kuroe K, Shimpo H, Nakano M, Komada Y.
    Circulation; 2005 Jan 04; 111(1):38-43. PubMed ID: 15611368
    [Abstract] [Full Text] [Related]

  • 5. [Clinical features of recurrent Kawasaki disease in 20 children].
    Zou LX, Gong FQ.
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Oct 04; 10(5):617-9. PubMed ID: 18947484
    [Abstract] [Full Text] [Related]

  • 6. Infections and Kawasaki disease: implications for coronary artery outcome.
    Benseler SM, McCrindle BW, Silverman ED, Tyrrell PN, Wong J, Yeung RS.
    Pediatrics; 2005 Dec 04; 116(6):e760-6. PubMed ID: 16322132
    [Abstract] [Full Text] [Related]

  • 7. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease.
    Kobayashi T, Inoue Y, Takeuchi K, Okada Y, Tamura K, Tomomasa T, Kobayashi T, Morikawa A.
    Circulation; 2006 Jun 06; 113(22):2606-12. PubMed ID: 16735679
    [Abstract] [Full Text] [Related]

  • 8. Kawasaki disease with lymphadenopathy and fever as sole initial manifestations.
    Kubota M, Usami I, Yamakawa M, Tomita Y, Haruta T.
    J Paediatr Child Health; 2008 Jun 06; 44(6):359-62. PubMed ID: 18476929
    [Abstract] [Full Text] [Related]

  • 9. [Risk factors for coronary artery lesions in children with Kawasaki disease].
    Li Y, Wang XM, Liu YL, Shi K, Yang YF, Guo YH.
    Zhongguo Dang Dai Er Ke Za Zhi; 2012 Dec 06; 14(12):938-41. PubMed ID: 23234782
    [Abstract] [Full Text] [Related]

  • 10. Kawasaki disease with severe cardiac sequelae: lessons from recent New Zealand experience.
    Wilson N, Heaton P, Calder L, Nicholson R, Stables S, Gavin R.
    J Paediatr Child Health; 2004 Dec 06; 40(9-10):524-9. PubMed ID: 15367145
    [Abstract] [Full Text] [Related]

  • 11. Relationship between adipokines and coronary artery aneurysm in children with Kawasaki disease.
    Liu R, He B, Gao F, Liu Q, Yi Q.
    Transl Res; 2012 Aug 06; 160(2):131-6. PubMed ID: 22683371
    [Abstract] [Full Text] [Related]

  • 12. Criterion for early prediction of coronary artery involvement by clinical manifestations in patients with Kawasaki disease.
    Ishihara H, Izumida N, Hosaki J.
    Bull Tokyo Med Dent Univ; 1985 Jun 06; 32(2):77-89. PubMed ID: 3864563
    [Abstract] [Full Text] [Related]

  • 13. Clinical relevance of the risk factors for coronary artery lesions in Kawasaki disease.
    Weng KP, Hsieh KS, Huang SH, Ou SF, Ma CY, Ho TY, Lai CR, Ger LP.
    Kaohsiung J Med Sci; 2012 Jan 06; 28(1):23-9. PubMed ID: 22226058
    [Abstract] [Full Text] [Related]

  • 14. Tissue inhibitor of metalloproteinase 2 and coronary artery lesions in Kawasaki disease.
    Furuno K, Takada H, Yamamoto K, Ikeda K, Ohno T, Khajoee V, Mizuno Y, Hara T.
    J Pediatr; 2007 Aug 06; 151(2):155-60, 160.e1. PubMed ID: 17643768
    [Abstract] [Full Text] [Related]

  • 15. Clinical characteristics of Kawasaki disease according to age at diagnosis.
    Kim SH, Kim KH, Kim DS.
    Indian Pediatr; 2009 Jul 06; 46(7):585-90. PubMed ID: 19638657
    [Abstract] [Full Text] [Related]

  • 16. Study on the relationship between mean platelet volume and platelet distribution width with coronary artery lesion in children with Kawasaki disease.
    Liu R, Gao F, Huo J, Yi Q.
    Platelets; 2012 Jul 06; 23(1):11-6. PubMed ID: 21675937
    [Abstract] [Full Text] [Related]

  • 17. [Mucocutaneous lymph node syndrome (Kawasaki disease) in 2 children].
    Szychowska Z, Gruszka J, Kuchar E.
    Przegl Epidemiol; 1996 Jul 06; 50(3):273-9. PubMed ID: 8927738
    [Abstract] [Full Text] [Related]

  • 18. [Value of serum soluble interleukin-2R, interleukin-6 and C-reactive protein in the early diagnosis of Kawasaki disease].
    Peng Q, Wu Q, Chen CH, Hong H, Zhang LY.
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Jun 06; 8(3):208-10. PubMed ID: 16787593
    [Abstract] [Full Text] [Related]

  • 19. [How does the time of diagnosis affect the course of disease in children with kawasaki syndrome? A retrospective analysis at one center].
    Raith W, Gamillscheg A, Heinzl B, Nagel BH, Koestenberger M, Beitzke A.
    Klin Padiatr; 2009 Jun 06; 221(2):83-8. PubMed ID: 19263328
    [Abstract] [Full Text] [Related]

  • 20. Clinical spectrum of Kawasaki disease in infants.
    Tseng CF, Fu YC, Fu LS, Betau H, Chi CS.
    Zhonghua Yi Xue Za Zhi (Taipei); 2001 Mar 06; 64(3):168-73. PubMed ID: 11458622
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.